164 related articles for article (PubMed ID: 36822623)
1. Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis.
Tan Y; Wu D; Liu ZY; Yu HQ; Zheng XR; Lin XT; Bie P; Zhang LD; Xie CM
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36822623
[TBL] [Abstract][Full Text] [Related]
2. β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.
Lu Y; Li X; Liu H; Xue J; Zeng Z; Dong X; Zhang T; Wu G; Yang K; Xu S
Oncogene; 2021 Feb; 40(7):1269-1283. PubMed ID: 33420362
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
[TBL] [Abstract][Full Text] [Related]
4. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression.
Cen X; Lu Y; Lu J; Zhan P; Cheng Y; Luo C; Liu J; Xie C; Wang F
Hum Cell; 2023 Jul; 36(4):1477-1484. PubMed ID: 37227687
[TBL] [Abstract][Full Text] [Related]
6. Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.
Shi Z; Wu X; Ke Y; Wang L
Dig Dis Sci; 2016 Mar; 61(3):785-94. PubMed ID: 26520111
[TBL] [Abstract][Full Text] [Related]
7. A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase.
Peng T; Wonganan O; Zhang Z; Yu J; Xi R; Cao Y; Suksamrarn A; Zhang G; Wang F
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805945
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
[No Abstract] [Full Text] [Related]
9. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
Qiao Y; Zhang Y; Wang J
Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
[TBL] [Abstract][Full Text] [Related]
10. p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.
Luo YD; Fang L; Yu HQ; Zhang J; Lin XT; Liu XY; Wu D; Li GX; Huang D; Zhang YJ; Chen S; Jiang Y; Shuai L; He Y; Zhang LD; Bie P; Xie CM
J Hepatol; 2021 Jan; 74(1):96-108. PubMed ID: 32738450
[TBL] [Abstract][Full Text] [Related]
11. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
Liu F; Zhang W; Yang F; Feng T; Zhou M; Yu Y; Yu X; Zhao W; Yi F; Tang W; Lu Y
Sci Rep; 2016 Feb; 6():21260. PubMed ID: 26879559
[TBL] [Abstract][Full Text] [Related]
13. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation.
Deng L; Qian G; Zhang S; Zheng H; Fan S; Lesinski GB; Owonikoko TK; Ramalingam SS; Sun SY
Oncogene; 2019 Aug; 38(35):6270-6282. PubMed ID: 31316145
[TBL] [Abstract][Full Text] [Related]
15. Glutamine regulates the cellular proliferation and cell cycle progression by modulating the mTOR mediated protein levels of β-TrCP.
Malakar P; Singha D; Choudhury D; Shukla S
Cell Cycle; 2023 Sep; 22(17):1937-1950. PubMed ID: 37771151
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma.
Li X; Zhang CC; Lin XT; Zhang J; Zhang YJ; Yu HQ; Liu ZY; Gong Y; Zhang LD; Xie CM
Exp Mol Med; 2024 Feb; 56(1):177-191. PubMed ID: 38177295
[TBL] [Abstract][Full Text] [Related]
18. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
[TBL] [Abstract][Full Text] [Related]
19. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.
Westbrook TF; Hu G; Ang XL; Mulligan P; Pavlova NN; Liang A; Leng Y; Maehr R; Shi Y; Harper JW; Elledge SJ
Nature; 2008 Mar; 452(7185):370-4. PubMed ID: 18354483
[TBL] [Abstract][Full Text] [Related]
20. HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway.
Xu Y; Ke S; Lu S; Wang C; Li Z; Feng Z; Yu H; Bai M; Qian B; Yin B; Li X; Hua Y; Jiang H; Ma Y
Oncogenesis; 2023 Jan; 12(1):2. PubMed ID: 36670110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
